Events › B2B Event
B2B Event
A conference focused on Antibody-Drug Conjugates (ADCs) and novel conjugation technologies for targeted therapeutics. The 2026 event covers advances in conjugation chemistry, analytical control, safety, and scale-up manufacturing.
Filter this event to your ICP.
Hundreds of exhibitors here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
⚠️ The exhibitor list for this event isn't publicly accessible yet. We'll work on it once you submit a request.
Why people attend
To explore new payload delivery methods, find novel conjugation technologies, and network with leading scientists and drug developers in the ADC space.
Exhibitor categories
Sample matches
Filtered to a Series-B SaaS ICP. Your filter will be different.
Sample Match A
example.com
"Strong ICP match: Series B, EU expansion, VP Engineering and CTO attending."
Sample Match B
example.io
"Mid-stage SaaS with active GTM motion; product-led growth signals align with ICP."
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
More B2B Event events
More events in United States
Frequently asked questions